by Paul | 4th December 2023 | News
Top-line Efficacy and Safety Data on Track for Release in December 2023 London and New York, NY, December 4, 2023. OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of inflammatory...